DISCOUNT ZERTIFIKAT - CVS HEALTH Stock

Certificat

DE000PC56NV0

Real-time Bid/Ask 07:02:42 2024-06-27 EDT
51.38 EUR / 51.6 EUR +0.80% Intraday chart for DISCOUNT ZERTIFIKAT - CVS HEALTH
Current month+8.13%
1 month+7.97%
Date Price Change
24-06-27 51.47 +0.76%
24-06-26 51.08 -2.39%
24-06-25 52.33 +0.52%
24-06-24 52.06 +0.58%
24-06-21 51.76 +0.14%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 04:15 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC56NV
ISINDE000PC56NV0
Date issued 2024-03-04
Cap 85 $
Last trading day 2025-12-19
Maturity 2025-12-19 (541 Days)
Parity 1 : 1
Emission price 59.11
Emission volume N/A
Payment day 2025-12-29
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 8.854 %
Sideways yield 9.948 %
Sideways yield pa 6.620 %
Outperformance point 93.26 $
Break even 55.14 €
Highest since issue 62.44
Lowest since issue 45.07
Spread 0.22
Spread %0.43%
Distance Cap -24.37 $
Distance Cap %-40.19%
Max. earning 27.9
Max. earning % 54.14 %

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus